Quick Heal Technologies share price today

Quick Heal Technologies Ltd's share price was ₹146.49 at the close on 4 November 2026. It has been falling for 90 weeks. That is 19.5% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹133 and ₹318, and at that close it sat 8% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Quick Heal Technologies Ltd is in stage 4. The phase helps read everything below.

Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 2 weeks in a row.

Over the last 11 years the share price moved −26% while the NIFTY 500 moved +257%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

5 points on a year earlier.

1. Promoters cut their stake for 13 quarters in a row

   From 73.1% to 71.5% of the company by the September 2026 quarter.

2. Operating margin down 7.5 points on a year earlier

   3.5% in the September 2026 quarter, from 11.1%.

   Why: The margin fell because revenue was down 22% from a year earlier while total spending excluding depreciation stayed flat.

   Next results: check whether enterprise orders already booked turn into sales and narrow the drop in yearly revenue.

   From the earnings call on 28 Oct 2026.

For July to September 2026 (the quarter ended 30 September 2026), Quick Heal Technologies reported revenue of ₹64.9 crore, down 22.3% from ₹83.5 crore a year earlier, and a profit of ₹5.80 crore, down 26.7% from ₹7.91 crore.

Quick Heal Technologies results: July to September 2026 against a year earlier

The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

Quick Heal Technologies' management discussed these results on a call held on 28 October 2026; what it said is further down this page.

From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.

Quick Heal Technologies closed at ₹146.49 on 4 November 2026, down 53.3% from ₹313.85 a year earlier (7 November 2025) and down 36.7% over five years. Its highest weekly close since February 2016 was ₹811.70 on 11 October 2024.

Quick Heal Technologies share price: then and now

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

565 weekly closes from 26 February 2016 to 4 November 2026.

4 Nov 2026: Quick Heal Technologies closed at ₹146.49, down 5.2% on the week and up 6.0% on the month. 28 Oct 2026: Quick Heal Technologies held its results call for July to September 2026. Management guided: Enterprise contribution to grow beyond 80% in at least coming 3 years.

Earlier

• Results for July to September 2026: Revenue down 22.3% and profit down 26.7% on a year earlier.

Quick Heal Technologies paid no dividend in the 12 months to 5 November 2026. The last was a dividend of ₹3 a share, ex-date 30 August 2024.

Quick Heal Technologies dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date.

Not in its latest year. Quick Heal Technologies Ltd paid out 0% of its profit as dividends in FY26. It did pay a dividend in 11 of its last 13 reported years, so there is a history but no current dividend.

From the NSE corporate-actions record, read 5 November 2026.

On the call for July to September 2026, held on 28 October 2026, Quick Heal Technologies' management guided: Enterprise contribution to grow beyond 80% in at least coming 3 years.

“The traction is that, over at least the coming 3 years, we anticipate that the contribution from enterprise will grow beyond 80%”Dr. Sanjay Katkar, on the call for July to September 2026

What management guided

• Seqrite Data Privacy to match endpoint scale over medium to long term.
• Employee cost to remain in similar range with selective adds where gaps exist.
• International to build meaningful positions in fewer markets rather than spread thin.
• Consumer near-term volume to stay moderated under tightened credit to improve quality and discipline.

Management’s own plans and goals, from our notes of the call. A plan is not a result.

Source: the call transcript.

From the call for July to September 2026, 28 October 2026.

When Quick Heal Technologies reports October to December 2026, these are the 3 checks that show whether the story is still on course. First: Enterprise recognised revenue sustains on the previous quarter rebound and narrows on a year earlier decline as flagged deferred and order cover converts to sales.

Quick Heal Technologies is on one of our India lists: IT stocks.

Quick Heal Technologies Ltd earned ₹5.8 Cr of net profit in the Sep 2026 quarter, −26.7% on the same quarter a year earlier. The full FY26 year was a loss of ₹11.0 Cr. That is 8.9% of the quarter's revenue. The same quarter a year earlier earned ₹7.9 Cr. 4 of the last 12 reported quarters were loss-making.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

For the full year, FY26 profit was −₹11.0 Cr (−320.0% on the year before).

Quick Heal Technologies Ltd reported ₹64.9 Cr of revenue in the Sep 2026 quarter, −22.3% on the same quarter a year earlier. Over 10 years it has grown −1.4% a year on average. The last full year, FY26, came in at ₹261 Cr. The last four reported quarters add to ₹230 Cr.

Revenue is everything the company billed its customers in the period.

FY26 revenue was ₹261 Cr, −6.8% on the year before.

Recent pace: the last four quarters grew −16.9% on average, against −1.4% a year over the longer run, so this year is growing slower than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew −16.7%, against −13.2% a year over the last 8 quarters (rolling over).

Quick Heal Technologies Ltd's operating margin was 3.5% in the Sep 2026 quarter, 7.5 percentage points lower than the same quarter a year ago. Across 13 years it has been between −11.0% and 42.0%. The latest quarter is within that range.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed −7.5 percentage points on the year while gross margin changed +1.4 points. So the drop came mostly from costs below the gross margin, such as staff and overheads, measured against sales.

Over the last 3 years, 77% of Quick Heal Technologies Ltd's reported profit came in as cash from its operations, so most of the profit is real cash. In FY26 it brought in ₹15.0 Cr of operating cash against −₹11.0 Cr of profit.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

After ₹17.0 Cr of spending on assets, free cash was −₹2.0 Cr: it spent more than its operations brought in.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason.

What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building.

Quick Heal Technologies Ltd's customer, stock and supplier day counts come out in the thousands of days on sales this small (₹261 Cr in FY26), so no cash-cycle chart is drawn and this section looks at its spending on assets instead. It spent ₹38.0 Cr on assets over the last 3 years.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

Averaged over those years that is 4.9% of FY26 revenue a year.

Spending on assets: ₹38.0 Cr over the last 3 years, against ₹40.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is spending about what it takes to replace what wears out, or less. Work still in progress is ₹0.0 Cr (FY26): assets paid for that are not earning yet.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

Quick Heal Technologies Ltd's P/E is 196.4×, about the highest it has ever been. Its usual P/E (the middle reading) is 19.3×, over 10 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.